查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1620750

精準醫療市場：依技術、應用程式、最終用戶、配置- 2025-2030 年全球預測

Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Companion Diagnostics), Application (CNS, Immunology, Oncology), End-User, Deployment - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年精準醫療市場估值為681.2億美元，預計2024年將達757億美元，複合年成長率為11.22%，預計2030年將達1434.3億美元。

精準醫學考慮遺傳、環境方面和生活方式等因素，根據每位患者的個別特徵制定治療方案。這種方法透過實現更個人化和有效的醫療保健解決方案正在重塑醫療實踐。癌症、心血管疾病和遺傳性疾病等疾病管理中對個人化治療計劃的需求不斷成長，推動了對精準醫療的需求，這些計劃有可能改善患者的治療效果並降低醫療成本。精準醫學的應用範圍涵蓋基因組學、數位健康技術和生物標記分析，對於藥物開發、早期疾病檢測和治療方法選擇至關重要。最終用途範圍廣泛，影響生物製藥、診斷公司和醫療保健提供者等行業。成長要素包括基因組學的進步、研發投資的增加以及對標靶治療的日益重視。此外，政府的支持以及生物技術公司和學術機構之間的合作正在支持市場擴張。新的商機在於人工智慧驅動的基因組分析和巨量資料的整合以增強預測結果。對於希望抓住這些機會的公司來說，投資資料分析並建立創新解決方案的夥伴關係關係至關重要。然而，存在一些可能抑製成長的挑戰，例如高開發成本、資料隱私問題和監管障礙。醫療保健提供者和患者的認知和接受度有限也是一個主要障礙。創新的最佳領域包括開發具有成本效益的基因組技術和精確診斷的進步。透過探索促進患者可及性和參與度的新經營模式，預計將進一步成長。市場本質上是動態的，快速的技術進步需要相關人員的敏捷性和遠見。公司應專注於整合最尖端科技並創建可擴展的解決方案，以保持競爭力，同時滿足個人化醫療保健的細微差別需求。

主要市場統計
基準年[2023] 681.2億美元
預計年份 [2024] 757億美元
預測年份 [2030] 1434.3億美元
複合年成長率（%） 11.22%

市場動態：揭示快速發展的精準醫療市場的關鍵市場洞察

供需的動態交互作用正在改變精準醫療市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 更多政府資助和更多線上協作論壇
    • 人工智慧在精準醫療的應用不斷增加
    • 新興企業積極進入，癌症生物學取得進展
  • 市場限制因素
    • 精準醫療治療缺乏報銷
  • 市場機會
    • 精準醫療中擴大採用雲端基礎的解決方案
    • 製藥公司與軟體公司建立策略夥伴關係來表徵基因
  • 市場挑戰
    • FDA 複雜藥物治療核准率

波特五力：駕馭精準醫療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解精準醫療市場的外部影響

外部宏觀環境因素在塑造精準醫療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解精準醫療市場競爭態勢

精準醫療市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣精準醫療市場廠商績效評估

FPNV定位矩陣是評估精準醫療市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了精準醫療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，精準醫療市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 更多政府資助和更多線上協作論壇
      • 人工智慧在精準醫療的應用不斷增加
      • Start-Ups的活躍補充了癌症生物學的進步
    • 抑制因素
      • 缺乏精準醫學治療的覆蓋範圍
    • 機會
      • 精準醫療中擴大採用雲端基礎的解決方案
      • 製藥公司和軟體公司建立策略聯盟來表徵基因
    • 任務
      • FDA 複雜藥物治療核准率
  • 市場區隔分析
    • 技術：巨量資料分析正在推進精準醫療領域
    • 應用：使用精準醫學進行個人化癌症和腫瘤護理
    • 最終用戶：生技和診斷公司為推動精準醫療領域的研發投資和努力。
    • 部署：融合AI和雲端解決方案，提升精準醫療服務開發效率與速度
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章精準醫療市場：依技術分類

  • 巨量資料分析
  • 生物資訊學
  • 伴同性診斷
  • 藥物發現
  • 基因序列分析

第7章精準醫療市場：依應用分類

  • 中樞神經系統
  • 免疫學
  • 腫瘤學
  • 呼吸系統

第8章精準醫療市場：依最終用戶分類

  • 生物技術和診斷公司
  • 研究所/製藥
  • 研究中心和政府機構

第9章精準醫療市場：依發展分類

  • 在雲端
  • 本地

第10章美洲精準醫療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太精準醫療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲精準醫療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Tirona 籌集 750 萬歐元新資金籌措，以加速精準醫療突破性創新的實施
    • 諾華完成對精準醫療開發商 Chinook 的收購
    • 達特茅斯學院的新中心利用人工智慧改善健康結果
  • 戰略分析和建議

公司名單

  • AccessDX Holdings
  • Adaptive Biotechnologies Corporation
  • Biocrates Life Sciences AG
  • bioMerieux SA
  • Caris Life Sciences
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • Foundation Medicine, Inc.
  • Guardant Health, Inc.
  • healthOme
  • Illumina, Inc.
  • Intomics by ZS Associates, Inc.
  • Invitae Corporation.
  • Laboratory Corporation of America Holdings
  • Medtronic PLC
  • Natera Inc.
  • Novartis AG
  • Pfizer Inc.
  • Precision Medicine Group, LLC
  • QIAGEN GmbH
  • Quest Diagnostics Incorporated
  • Strata Oncology, Inc.
  • Syapse, Inc.
  • Tempus Labs, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-030EE48515D0

The Precision Medicine Market was valued at USD 68.12 billion in 2023, expected to reach USD 75.70 billion in 2024, and is projected to grow at a CAGR of 11.22%, to USD 143.43 billion by 2030.

Precision medicine involves tailoring medical treatment to the individual characteristics of each patient, considering factors like genetics, environmental aspects, and lifestyle. This approach is reshaping medical practices by allowing more personalized and effective healthcare solutions. The necessity for precision medicine is underscored by its potential to improve patient outcomes and reduce healthcare costs, catering to the heightened need for personalized treatment plans in managing diseases like cancer, cardiovascular conditions, and genetic disorders. In terms of application, precision medicine spans genomics, digital health technologies, and biomarker analysis, making it pivotal in drug development, early detection of diseases, and therapy selection. The end-use scope is broad, affecting sectors such as biopharmaceuticals, diagnostic companies, and healthcare providers. Influencing growth factors include advancements in genomics, increased R&D investments, and a growing emphasis on targeted therapies. Moreover, governmental support, combined with collaborations between biotech firms and academic institutions, is driving market expansion. Emerging opportunities lie in AI-driven genomic analytics and the integration of big data to enhance predictive outcomes. For businesses aiming to seize these opportunities, investing in data analytics and forging partnerships for innovative solutions will be critical. However, there are challenges like high costs of development, data privacy concerns, and regulatory hurdles that could impede growth. Limited awareness and acceptance among healthcare providers and patients also pose significant barriers. The best areas for innovation include developing cost-effective genomic technologies and advancing precision diagnostics. Exploring new business models that promote patient accessibility and engagement can unlock additional growth. The market is inherently dynamic, with rapid technological advancements necessitating agility and foresight from stakeholders. Businesses should focus on integrating cutting-edge technologies and creating scalable solutions to remain competitive while addressing the nuanced demands of personalized healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 68.12 billion
Estimated Year [2024] USD 75.70 billion
Forecast Year [2030] USD 143.43 billion
CAGR (%) 11.22%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Precision Medicine Market

The Precision Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising government funding and rising online collaborative forums
    • Increasing use of artificial intelligence in precision medicine
    • Advancement in cancer biology complemented by the active presence of startups
  • Market Restraints
    • Lack of reimbursement for precision medicine-based treatment
  • Market Opportunities
    • Growing adoption of cloud-based solutions in precision medicine
    • Strategic alliances among pharmaceutical and software companies to characterize the genes
  • Market Challenges
    • Complicated FDA pharmacotherapy approval rate

Porter's Five Forces: A Strategic Tool for Navigating the Precision Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Precision Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Precision Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Precision Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Precision Medicine Market

A detailed market share analysis in the Precision Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Precision Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Precision Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Precision Medicine Market

A strategic analysis of the Precision Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Precision Medicine Market, highlighting leading vendors and their innovative profiles. These include AccessDX Holdings, Adaptive Biotechnologies Corporation, Biocrates Life Sciences AG, bioMerieux SA, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Foundation Medicine, Inc., Guardant Health, Inc., healthOme, Illumina, Inc., Intomics by ZS Associates, Inc., Invitae Corporation., Laboratory Corporation of America Holdings, Medtronic PLC, Natera Inc., Novartis AG, Pfizer Inc., Precision Medicine Group, LLC, QIAGEN GmbH, Quest Diagnostics Incorporated, Strata Oncology, Inc., Syapse, Inc., Tempus Labs, Inc., Teva Pharmaceutical Industries Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Precision Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Big Data Analytics, Bioinformatics, Companion Diagnostics, Drug Discovery, and Gene Sequencing.
  • Based on Application, market is studied across CNS, Immunology, Oncology, and Respiratory.
  • Based on End-User, market is studied across Biotechnology & Diagnostic Companies, Laboratories & Pharmaceuticals, and Research Centers & Government Institutions.
  • Based on Deployment, market is studied across On-Cloud and On-Premise.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government funding and rising online collaborative forums
      • 5.1.1.2. Increasing use of artificial intelligence in precision medicine
      • 5.1.1.3. Advancement in cancer biology complemented by the active presence of startups
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement for precision medicine-based treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adoption of cloud-based solutions in precision medicine
      • 5.1.3.2. Strategic alliances among pharmaceutical and software companies to characterize the genes
    • 5.1.4. Challenges
      • 5.1.4.1. Complicated FDA pharmacotherapy approval rate
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Big data analytics is advancing the field of precision medicine
    • 5.2.2. Application: Personalized cancer and oncology care using precision medicine
    • 5.2.3. End-user: Efforts by biotechnology and diagnostic companies to invest in R&D and advance the field of precision medicine
    • 5.2.4. Deployment: Integration of AI and cloud solutions to improve efficacy and speed of development of precision medicine services
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Precision Medicine Market, by Technology

  • 6.1. Introduction
  • 6.2. Big Data Analytics
  • 6.3. Bioinformatics
  • 6.4. Companion Diagnostics
  • 6.5. Drug Discovery
  • 6.6. Gene Sequencing

7. Precision Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. CNS
  • 7.3. Immunology
  • 7.4. Oncology
  • 7.5. Respiratory

8. Precision Medicine Market, by End-User

  • 8.1. Introduction
  • 8.2. Biotechnology & Diagnostic Companies
  • 8.3. Laboratories & Pharmaceuticals
  • 8.4. Research Centers & Government Institutions

9. Precision Medicine Market, by Deployment

  • 9.1. Introduction
  • 9.2. On-Cloud
  • 9.3. On-Premise

10. Americas Precision Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Precision Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Precision Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Thirona Raises EUR 7.5 Million New Financing to Accelerate the Adoption of its Breakthrough Innovations for Precision Medicine
    • 13.3.2. Novartis completes acquisition of precision medicine developer Chinook
    • 13.3.3. New Dartmouth Center Applies AI to Improve Health Outcomes
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AccessDX Holdings
  • 2. Adaptive Biotechnologies Corporation
  • 3. Biocrates Life Sciences AG
  • 4. bioMerieux SA
  • 5. Caris Life Sciences
  • 6. Exact Sciences Corporation
  • 7. F. Hoffmann-La Roche AG
  • 8. Foundation Medicine, Inc.
  • 9. Guardant Health, Inc.
  • 10. healthOme
  • 11. Illumina, Inc.
  • 12. Intomics by ZS Associates, Inc.
  • 13. Invitae Corporation.
  • 14. Laboratory Corporation of America Holdings
  • 15. Medtronic PLC
  • 16. Natera Inc.
  • 17. Novartis AG
  • 18. Pfizer Inc.
  • 19. Precision Medicine Group, LLC
  • 20. QIAGEN GmbH
  • 21. Quest Diagnostics Incorporated
  • 22. Strata Oncology, Inc.
  • 23. Syapse, Inc.
  • 24. Tempus Labs, Inc.
  • 25. Teva Pharmaceutical Industries Ltd.
  • 26. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. PRECISION MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. PRECISION MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PRECISION MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECISION MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIG DATA ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GENE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECISION MEDICINE MARKET SIZE, BY CNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECISION MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECISION MEDICINE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOTECHNOLOGY & DIAGNOSTIC COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PRECISION MEDICINE MARKET SIZE, BY LABORATORIES & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECISION MEDICINE MARKET SIZE, BY RESEARCH CENTERS & GOVERNMENT INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 193. PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023